CAFG - ETF AI Analysis

Top Page

Pacer US Small Cap Cash Cows Growth Leaders ETF (CAFG)

Rating:72Outperform

Price Target:―

CAFG, the Pacer US Small Cap Cash Cows Growth Leaders ETF, appears to offer a generally solid quality profile, driven by strong contributors like Krystal Biotech, Powell Industries, Veracyte, and Innovex, which combine healthy financial performance, positive earnings commentary, and supportive technical trends. However, holdings such as Semtech, DigitalOcean, and PTC Therapeutics introduce some drag on the rating due to high leverage, valuation concerns, and mixed profitability. The main risk factor is stock-specific financial and valuation risk across several smaller companies, rather than any single dominant sector or holding.

Positive Factors

Strong Recent Performance

The ETF has shown solid gains over the past month, three months, and year-to-date, indicating positive recent momentum.

Leading Holdings With Strong Gains

Several of the largest positions, such as Vicor and Powell Industries, have delivered strong year-to-date performance, helping drive the fund’s returns.

Focused Growth Sectors

Heavy exposure to technology and health care gives investors targeted access to sectors that have been key drivers of growth in the small-cap space.

Negative Factors

Relatively High Expense Ratio

The fund’s expense ratio is on the higher side for an ETF, which can eat into long-term returns compared with lower-cost options.

Concentration in a Few Sectors

A large share of assets is concentrated in technology and health care, increasing the impact if these sectors experience a downturn.

Single-Country Exposure

With almost all holdings in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. market.

CAFG vs. SPDR S&P 500 ETF (SPY)

AUM20.29M

RegionNorth America

Expense Ratio0.59%

Beta0.90

IssuerPacer

Inception DateMay 02, 2023

Dividend Yield0.32%

Asset ClassEquity

Index TrackedPacer US Small Cap Cash Cows Growth Leaders Index - Benchmark TR Gross

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume9,253

30 Day Avg. Volume5,630

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

32.15

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering99

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

CAFG Summary

The Pacer US Small Cap Cash Cows Growth Leaders ETF (CAFG) tracks the Pacer US Small Cap Cash Cows Growth Leaders Index, focusing on smaller U.S. companies with strong cash flow and growth potential. It mainly holds technology and health care stocks, including names like DigitalOcean Holdings and Semtech. Someone might invest in this ETF to seek higher long-term growth and diversify beyond large, well-known companies by tapping into innovative small businesses. However, because it focuses on small, growth-oriented stocks, its price can be more volatile and may go up and down more sharply than the overall market.

How much will it cost me?The Pacer US Small Cap Cash Cows Growth Leaders ETF (CAFG) has an expense ratio of 0.59%, meaning you’ll pay $5.90 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on identifying small-cap companies with strong growth and cash flow potential.

What would affect this ETF?The Pacer US Small Cap Cash Cows Growth Leaders ETF (CAFG) could benefit from strong growth in sectors like technology and healthcare, which make up a significant portion of its holdings, especially if innovation and demand in these areas continue to thrive. However, small-cap stocks are often more sensitive to economic downturns and interest rate hikes, which could negatively impact the ETF's performance. Additionally, regulatory changes or sector-specific challenges in industries like energy or consumer cyclical could pose risks to its growth potential.

CAFG Top 10 Holdings

CAFG is leaning hard into U.S. small-cap growth, with a clear tilt toward tech and health care names that are either sprinting ahead or catching their breath. Vicor and Powell Industries are doing much of the heavy lifting, with rising share prices that set the tone for the fund. Krystal Biotech and Innovex are also adding fuel, reflecting strong momentum in innovative niches. On the flip side, Veracyte and PTC Therapeutics are lagging a bit, acting like mild headwinds rather than full-on drags in this otherwise growth-focused, domestically concentrated portfolio.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
VICR	Vicor	4.80%	$973.88K	$7.02B	207.59%	73 Outperform
POWL	Powell Industries	4.43%	$898.06K	$6.82B	179.38%	76 Outperform
SMTC	Semtech	3.42%	$693.92K	$8.11B	130.38%	69 Neutral
DOCN	DigitalOcean Holdings	2.68%	$543.04K	$6.19B	45.98%	73 Outperform
KRYS	Krystal Biotech	2.65%	$537.11K	$8.35B	60.80%	80 Outperform
KLIC	Kulicke & Soffa	2.23%	$451.65K	$3.76B	58.83%	61 Neutral
PTCT	PTC Therapeutics	2.15%	$435.43K	$5.55B	36.70%	72 Outperform
IDCC	InterDigital	2.13%	$431.28K	$9.41B	66.42%	76 Outperform
INVX	Innovex International	2.11%	$428.72K	$1.69B	49.23%	76 Outperform
MD	Pediatrix Medical Group	2.11%	$427.77K	$1.86B	55.70%	76 Outperform

CAFG Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

26.73

Positive

100DMA

26.10

Positive

200DMA

25.40

Positive

Market Momentum

MACD

0.36

Positive

RSI

59.09

Neutral

STOCH

69.34

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CAFG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.58, equal to the 50-day MA of 26.73, and equal to the 200-day MA of 25.40, indicating a bullish trend. The MACD of 0.36 indicates Positive momentum. The RSI at 59.09 is Neutral, neither overbought nor oversold. The STOCH value of 69.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CAFG.

CAFG Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
CAFG	―	―	$20.29M	0.59%	―
TMFS	―	―	$69.99M	0.85%	―
MMSC	―	―	$43.75M	0.95%	―
QSML	―	―	$10.21M	0.38%	―
ACSG	―	―	$8.36M	0.49%	―
SAWS	―	―	$6.73M	0.55%	―

Performance Comparison

CAFG

Pacer US Small Cap Cash Cows Growth Leaders ETF

27.90

2.06

7.97%

TMFS

Motley Fool Small-Cap Growth ETF

―

MMSC

First Trust Multi-Manager Small Cap Opportunities ETF

―

QSML

WisdomTree U.S. SmallCap Quality Growth Fund

―

ACSG

American Century Small Cap Growth Insights ETF

―

SAWS

AAM Sawgrass US Small Cap Quality Growth ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents